These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 10752541
1. The enhanced contractility in phospholamban deficient mouse hearts is not associated with alterations in (Ca2+)-sensitivity or myosin ATPase-activity of the contractile proteins. Schwinger RH, Brixius K, Savvidou-Zaroti P, Bölck B, Zobel C, Frank K, Kranias EG, Hoischen S, Erdmann E. Basic Res Cardiol; 2000 Feb; 95(1):12-8. PubMed ID: 10752541 [Abstract] [Full Text] [Related]
3. Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts. Kiss E, Brittsan AG, Edes I, Grupp IL, Grupp G, Kranias EG. Circ Res; 1998 Sep 21; 83(6):608-13. PubMed ID: 9742056 [Abstract] [Full Text] [Related]
5. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Schwinger RH, Böhm M, Schmidt U, Karczewski P, Bavendiek U, Flesch M, Krause EG, Erdmann E. Circulation; 1995 Dec 01; 92(11):3220-8. PubMed ID: 7586307 [Abstract] [Full Text] [Related]
11. Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. Kiss E, Jakab G, Kranias EG, Edes I. Circ Res; 1994 Aug 15; 75(2):245-51. PubMed ID: 8033338 [Abstract] [Full Text] [Related]
12. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility. Neumann J, Boknik P, DePaoli-Roach AA, Field LJ, Rockman HA, Kobayashi YM, Kelley JS, Jones LR. J Mol Cell Cardiol; 1998 Oct 15; 30(10):1991-2002. PubMed ID: 9799653 [Abstract] [Full Text] [Related]
13. Phospholamban gene dosage effects in the mammalian heart. Luo W, Wolska BM, Grupp IL, Harrer JM, Haghighi K, Ferguson DG, Slack JP, Grupp G, Doetschman T, Solaro RJ, Kranias EG. Circ Res; 1996 May 15; 78(5):839-47. PubMed ID: 8620604 [Abstract] [Full Text] [Related]
15. Increased Ca2+-sensitivity of myofibrillar tension in heart failure and its functional implication. Brixius K, Savvidou-Zaroti P, Mehlhorn U, Bloch W, Kranias EG, Schwinger RH. Basic Res Cardiol; 2002 May 15; 97 Suppl 1():I111-7. PubMed ID: 12479244 [Abstract] [Full Text] [Related]
16. Targeted overexpression of the sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts. Baker DL, Hashimoto K, Grupp IL, Ji Y, Reed T, Loukianov E, Grupp G, Bhagwhat A, Hoit B, Walsh R, Marban E, Periasamy M. Circ Res; 2002 May 15; 83(12):1205-14. PubMed ID: 9851937 [Abstract] [Full Text] [Related]
17. Effect of ablation of phospholamban on dynamics of cardiac myocyte contraction and intracellular Ca2+. Wolska BM, Stojanovic MO, Luo W, Kranias EG, Solaro RJ. Am J Physiol; 1996 Jul 15; 271(1 Pt 1):C391-7. PubMed ID: 8760070 [Abstract] [Full Text] [Related]
18. Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart. Harrer JM, Haghighi K, Kim HW, Ferguson DG, Kranias EG. Am J Physiol; 1997 Jan 15; 272(1 Pt 2):H57-66. PubMed ID: 9038922 [Abstract] [Full Text] [Related]
19. Relationship between phospholamban and nucleotide activation of cardiac sarcoplasmic reticulum Ca2+ adenosinetriphosphatase. Coll KE, Johnson RG, McKenna E. Biochemistry; 1999 Feb 23; 38(8):2444-51. PubMed ID: 10029538 [Abstract] [Full Text] [Related]
20. Enhanced myocardial contractility and increased Ca2+ transport function in transgenic hearts expressing the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+-ATPase. Loukianov E, Ji Y, Grupp IL, Kirkpatrick DL, Baker DL, Loukianova T, Grupp G, Lytton J, Walsh RA, Periasamy M. Circ Res; 1998 Nov 02; 83(9):889-97. PubMed ID: 9797337 [Abstract] [Full Text] [Related] Page: [Next] [New Search]